In This Section

Abstracts

Poster PresentationWe encourage submission of abstracts to ASPET topic categories in all areas of pharmacology detailing your latest work.

By submitting your abstract, you will:

  • Receive feedback on your work
  • Be recognized for your recent scientific advances
  • Be visible to spur those conversations about collaboration
  • Have opportunities to win awards (for students and postdocs)

ASPET helps bring other scientists to you to discuss your work. Top scoring abstracts are designated as Program Committee Blue Ribbon Picks and are selected to give oral presentations at the ASPET Daily Datablitz and in division platform showcases.

ASPET regular, postdoc, and emeritus members can both submit their own work or sponsor the work of graduate students, undergraduates, and non-members. ASPET graduate student members may submit their own work but cannot sponsor others.

Award eligibility is based on student and postdoc submission to ASPET topic categories by the January 7, 2021 EB submission deadline. Be sure your ASPET membership is in good-standing to be eligible.

Abstract Submission Site to Open in Early November
Abstract Submission Deadline is Thursday, January 7, 2021

Submit your research to an ASPET topic category

How to be considered for ASPET Oral Presentations

Abstracts submitted by January 7th, 2021 by students and postdocs may also be considered for an oral presentation in related symposia, division platform sessions, or the ASPET Daily Datablitz sessions.  If selected for oral presentation, you will also be scheduled to present a poster. If your accepted abstract is not selected for an oral presentation, you will still be scheduled for a poster. No separate application is needed. When submitting your abstract to EB, be sure to select an ASPET topic category and be sure your ASPET membership is in good standing.

How to be considered for an ASPET Travel Award

Eligible students and postdocs must submit their work through EB to any ASPET category below AND complete the related ASPET application forms through the ASPET Award Portal. More information coming soon.

How to be considered for an ASPET Poster Award

Eligible students and postdocs must submit their work through EB to any ASPET category below and when prompted within the EB submission site, answer “yes” they want to be considered for the ASPET Poster Competition (Step 5-Awards).  Applications for ASPET poster awards close on Thursday, January 7th, 2021 when EB abstracts close. No other application is needed but have your ASPET membership ID number handy and be sure your membership is up to date (or join now!)

Criteria for Abstract Acceptance

Abstracts submitted for consideration will be reviewed by the ASPET Program Committee.  For acceptance for presentation and publication, abstracts must comply with the instructions and scientific integrity policy as outlined by the Experimental Biology meeting as well as meet the ASPET criteria below:

  • Scientific Merit (original concept, improvement of previous idea, expands the field)
  • Technical Quality (there are no major design or analysis issues)
  • Abstract is Complete (contains a clear and satisfactory Objective/Aim/Hypothesis, Design/Approach/Methods, Results, and Conclusion)
  • Relevance (contributes to improvement in scientific understanding)
  • Originality (no concerns about scientific integrity/plagiarism)
  • Language (satisfactory grammar/style and organization)

There is no guarantee that one’s abstract will be accepted or published.

Additionally, please be sure your abstract is in compliance with the EB Scientific Integrity Policy (link coming soon). Should be need to revise or withdraw your abstract after you have submitted it, please review the EB Abstract Withdrawal and Revision Policy (link coming soon).

Abstract Topic Categories


Cancer Pharmacology

3000-ASPET

Cancer Models

3001-ASPET

Drug Targets in Cancer

3002-ASPET

Anticancer Drug Response

3003-ASPET

Cancer Cell Signaling

3004-ASPET

Cancer Immunotherapy



Cardiovascular Pharmacology (CVP)

3005-ASPET

Cardiovascular Pharmacology

3006-ASPET

Vascular Pharmacology

3007-ASPET

Cardiac Pharmacology

3008-ASPET

Renal Pharmacology

3009-ASPET

Hypertension

3010-ASPET

Diabetes and Cardiovascular Disease



Cellular and Molecular Pharmacology

3011-ASPET

Receptor Trafficking, Desensitization, and Internalization

3012-ASPET

Allosterism and Biased Ligands

3013-ASPET

Novel Pathways and Targets

3014-ASPET

Modeling, Mutations, and Structural Studies

3015-ASPET

Receptors and Signal Transduction: General

3016-ASPET

GPCR Colloquium



Central Nervous System Pharmacology

3017-ASPET

Behavioral Pharmacology

3018-ASPET

Drugs of Abuse and Addiction - Behavior

3019-ASPET

Drugs of Abuse and Addiction - Cellular and Molecular

3020-ASPET

Neuropharmacology

3021-ASPET

CNS Transporters and Channels



Drug Discovery and Development

3022-ASPET

Drug Discovery and Development



Drug Metabolism and Disposition (DMD)

3023-ASPET

DMD - Other

3024-ASPET

DMD - Pharmacokinetics / Modeling

3025-ASPET

DMD - Metabolic Enzymes

3026-ASPET

DMD - Transporters

3027-ASPET

DMD - Regulation Factors



Pharmacogenomics and Translational Pharmacology

3028-ASPET

Translational Research

3029-ASPET

Clinical Pharmacology

3030-ASPET

Preclinical Pharmacology

3031-ASPET

Metabolic Pharmacology

3032-ASPET

Quantitative Systems / Precision Medicine

3033-ASPET

Regenerative Pharmacology

3034-ASPET

GI Pharmacology



Pharmacology Education

3035-ASPET

Pharmacology Education



Toxicology

3036-ASPET

Biochemical/Mechanistic Toxicology

3037-ASPET

Liver Toxicology

3038-ASPET

Neurotoxicology

3039-ASPET

In Vitro Toxicology

3040-ASPET

Inflammation and Tissue Injury

3041-ASPET

Natural Products



Pharmacology - Other

3042-ASPET

Pharmacology - COVID-19

3043-ASPET

Pharmacology - All Other

Last Updated: October 13, 2020
Key Dates
April 27 – 30, 2021

ASPET Annual Meeting at EB 2020

Thank you to our Annual Meeting partners:

jpet_banner
molpharm_banner
dmd_banner
pharmrev_banner